Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Press Release
Aug 10, 2020
| Rachel Schwartz
Lisa Steelman Joins AAM as Vice President, State Government Affairs
Press Release
Aug 6, 2020
| Rachel Schwartz
Generic and Biosimilar Industry Statement on Essential Medicines Executive Order
Video
Aug 6, 2020
| Erica Klinger
The Generic and Biosimilar Industry Has a Plan to Secure Our Medicines
Video
Aug 5, 2020
| Erica Klinger
AAM Interim CEO Jeff Francer: New Opportunities at the GRx+Biosims 2020 Virtual Conference
Video
Jul 31, 2020
| Erica Klinger
COVID-19 Response: Steve Giuli at Apotex
Blog
Jul 30, 2020
| Bob Billings
Thank you, Carole Ben-Maimon
Blog
Jul 29, 2020
| Jennifer Soup
GRx+Biosims 2020: Join Us Virtually November 9-11
Video
Jul 20, 2020
| Comms Temp
WiHP + LinkedIn Rock Your Profile Virtual Meeting
Press Release
Jul 2, 2020
| Rachel Schwartz
AAM Commends Introduction of the Increasing Access to Biosimilars Act
Blog
Jul 1, 2020
| Erik Komendant
Why—and How—the U.S. Should Develop a List of Essential Medicines
Blog
Jun 29, 2020
| Erica Klinger
America’s Patients: Share Your Story
Blog
Jun 26, 2020
| Bob Billings
Thank you, Desh Bandhu Gupta
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action